19 May 2013
Keywords: alk-abello, grazax, children, launched, uk, danish, firm
Article | 02 March 2009
Danish firm ALK-Abello's Grazax, a tablet-based immunotherapy product for grass pollen allergy, is now available for use in children and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
17 May 2013
© 2013 thepharmaletter.com